![](/images/general/no_picture/200_user.png)
Marc S Zimmer
Examiner (ID: 11482, Phone: (571)272-1096 , Office: P/1765 )
Most Active Art Unit | 1765 |
Art Unit(s) | 1765, 1796, 1712 |
Total Applications | 2564 |
Issued Applications | 2008 |
Pending Applications | 117 |
Abandoned Applications | 439 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7561816
[patent_doc_number] => 20110275649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'Combination therapy for the prevention of statin induced diabetes'
[patent_app_type] => utility
[patent_app_number] => 13/067016
[patent_app_country] => US
[patent_app_date] => 2011-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4398
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275649.pdf
[firstpage_image] =>[orig_patent_app_number] => 13067016
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/067016 | Combination therapy for the prevention of statin induced diabetes | May 2, 2011 | Abandoned |
Array
(
[id] => 6177571
[patent_doc_number] => 20110178055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'DUAL NK1/NK3 RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/076891
[patent_app_country] => US
[patent_app_date] => 2011-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 116061
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20110178055.pdf
[firstpage_image] =>[orig_patent_app_number] => 13076891
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/076891 | Dual NK1/NK3 receptor antagonists | Mar 30, 2011 | Issued |
Array
(
[id] => 8352066
[patent_doc_number] => 08247395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-21
[patent_title] => 'Topical skin care composition'
[patent_app_type] => utility
[patent_app_number] => 13/074744
[patent_app_country] => US
[patent_app_date] => 2011-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3725
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13074744
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/074744 | Topical skin care composition | Mar 28, 2011 | Issued |
Array
(
[id] => 8721243
[patent_doc_number] => 20130072459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND THE METHOD FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/636670
[patent_app_country] => US
[patent_app_date] => 2011-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8526
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636670
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/636670 | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND THE METHOD FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE USING THE SAME | Mar 22, 2011 | Abandoned |
Array
(
[id] => 8586912
[patent_doc_number] => 20130005733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'COMBINATION ANTI-CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/583396
[patent_app_country] => US
[patent_app_date] => 2011-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13941
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13583396
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/583396 | COMBINATION ANTI-CANCER THERAPY | Mar 8, 2011 | Abandoned |
Array
(
[id] => 7808059
[patent_doc_number] => 20120059013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'METHOD OF TREATING EARLY MORNING AKINESIA IN SUBJECTS HAVING PARKINSON\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/041880
[patent_app_country] => US
[patent_app_date] => 2011-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7032
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20120059013.pdf
[firstpage_image] =>[orig_patent_app_number] => 13041880
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/041880 | METHOD OF TREATING EARLY MORNING AKINESIA IN SUBJECTS HAVING PARKINSON'S DISEASE | Mar 6, 2011 | Abandoned |
Array
(
[id] => 6000904
[patent_doc_number] => 20110117196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects'
[patent_app_type] => utility
[patent_app_number] => 12/930805
[patent_app_country] => US
[patent_app_date] => 2011-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4298
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117196.pdf
[firstpage_image] =>[orig_patent_app_number] => 12930805
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/930805 | Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects | Jan 17, 2011 | Abandoned |
Array
(
[id] => 5944899
[patent_doc_number] => 20110105519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'Pharmaceutical Compositions for the Treatment of Sexual Disorders II'
[patent_app_type] => utility
[patent_app_number] => 12/987388
[patent_app_country] => US
[patent_app_date] => 2011-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14621
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105519.pdf
[firstpage_image] =>[orig_patent_app_number] => 12987388
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/987388 | Pharmaceutical Compositions for the Treatment of Sexual Disorders II | Jan 9, 2011 | Abandoned |
Array
(
[id] => 6125370
[patent_doc_number] => 20110086023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'COMBINATION ANTIHISTAMINE MEDICATION'
[patent_app_type] => utility
[patent_app_number] => 12/973299
[patent_app_country] => US
[patent_app_date] => 2010-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3427
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086023.pdf
[firstpage_image] =>[orig_patent_app_number] => 12973299
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/973299 | COMBINATION ANTIHISTAMINE MEDICATION | Dec 19, 2010 | Abandoned |
Array
(
[id] => 8516730
[patent_doc_number] => 20120316138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'PPAR-SPARING THIAZOLIDINEDIONES AND COMBINATIONS FOR THE TREATMENT OF OBESITY AND OTHER METABOLIC DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/515588
[patent_app_country] => US
[patent_app_date] => 2010-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 32508
[patent_no_of_claims] => 91
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515588
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/515588 | PPAR-SPARING THIAZOLIDINEDIONES AND COMBINATIONS FOR THE TREATMENT OF OBESITY AND OTHER METABOLIC DISEASES | Dec 14, 2010 | Abandoned |
Array
(
[id] => 6142268
[patent_doc_number] => 20110129507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'CONTROLLED RELEASE FORMULATIONS EXHIBITING AN ASCENDING RATE OF RELEASE'
[patent_app_type] => utility
[patent_app_number] => 12/953247
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 31153
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129507.pdf
[firstpage_image] =>[orig_patent_app_number] => 12953247
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/953247 | CONTROLLED RELEASE FORMULATIONS EXHIBITING AN ASCENDING RATE OF RELEASE | Nov 22, 2010 | Abandoned |
Array
(
[id] => 8253208
[patent_doc_number] => 20120157534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'COMPOSITIONS AND METHODS OF TREATMENT FOR INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/953387
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10037
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20120157534.pdf
[firstpage_image] =>[orig_patent_app_number] => 12953387
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/953387 | COMPOSITIONS AND METHODS OF TREATMENT FOR INFLAMMATORY DISEASES | Nov 22, 2010 | Abandoned |
Array
(
[id] => 8160449
[patent_doc_number] => 20120101156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'COMPOSITIONS COMPRISING A RETINOID AND AN NFkB-INHIBITOR AND THEIR METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/911038
[patent_app_country] => US
[patent_app_date] => 2010-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7396
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20120101156.pdf
[firstpage_image] =>[orig_patent_app_number] => 12911038
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/911038 | Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use | Oct 24, 2010 | Issued |
Array
(
[id] => 5929922
[patent_doc_number] => 20110039881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING MIDDLE-OF-THE-NIGHT INSOMNIA'
[patent_app_type] => utility
[patent_app_number] => 12/910721
[patent_app_country] => US
[patent_app_date] => 2010-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24288
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039881.pdf
[firstpage_image] =>[orig_patent_app_number] => 12910721
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/910721 | COMPOSITIONS AND METHODS FOR TREATING MIDDLE-OF-THE-NIGHT INSOMNIA | Oct 21, 2010 | Abandoned |
Array
(
[id] => 6202997
[patent_doc_number] => 20110065783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'HYDROXYLATED NEBIVOLOL METABOLITES'
[patent_app_type] => utility
[patent_app_number] => 12/908336
[patent_app_country] => US
[patent_app_date] => 2010-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 27100
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065783.pdf
[firstpage_image] =>[orig_patent_app_number] => 12908336
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/908336 | HYDROXYLATED NEBIVOLOL METABOLITES | Oct 19, 2010 | Abandoned |
Array
(
[id] => 9922937
[patent_doc_number] => 08980899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-17
[patent_title] => 'Methods of inhibiting Ire1'
[patent_app_type] => utility
[patent_app_number] => 13/502307
[patent_app_country] => US
[patent_app_date] => 2010-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 21553
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502307
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/502307 | Methods of inhibiting Ire1 | Oct 17, 2010 | Issued |
Array
(
[id] => 9113174
[patent_doc_number] => 08569346
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-10-29
[patent_title] => 'Thiazoline ring compounds as botulinum antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/904360
[patent_app_country] => US
[patent_app_date] => 2010-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5729
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12904360
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/904360 | Thiazoline ring compounds as botulinum antagonists | Oct 13, 2010 | Issued |
Array
(
[id] => 10000364
[patent_doc_number] => 09044437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-02
[patent_title] => 'Method for treating alzheimer\'s disease using pharmacological chaperones to increase the activity of gangliosidases'
[patent_app_type] => utility
[patent_app_number] => 13/501586
[patent_app_country] => US
[patent_app_date] => 2010-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21006
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501586
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/501586 | Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidases | Oct 11, 2010 | Issued |
Array
(
[id] => 6618511
[patent_doc_number] => 20100324079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'Medicament for prophylaxis and treatment of Alzheimer disease'
[patent_app_type] => utility
[patent_app_number] => 12/871242
[patent_app_country] => US
[patent_app_date] => 2010-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6620
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20100324079.pdf
[firstpage_image] =>[orig_patent_app_number] => 12871242
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/871242 | Medicament for prophylaxis and treatment of Alzheimer disease | Aug 29, 2010 | Abandoned |
Array
(
[id] => 8802450
[patent_doc_number] => 08440725
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-14
[patent_title] => 'Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria'
[patent_app_type] => utility
[patent_app_number] => 12/828713
[patent_app_country] => US
[patent_app_date] => 2010-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4667
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12828713
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/828713 | Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria | Jun 30, 2010 | Issued |